Effects of Delta-tocotrienol and Resveratrol Supplementation on Cardiometabolic Risk Factors, Biochemical Markers and microRNAs in Patients with Metabolic Syndrome

AFIP / National University of Medical Sciences0 个研究点开始时间: 待定最近更新: 2024年8月20日

适应症

试验速览

暂无简介。

•1.Both men and women
•2.Aged 18-60 years
•3.Participants who are diagnosed to have metabolic syndrome according to International Diabetic Federation -2005 Criteria; (South Asian specific waist circumference cut-off (>90 cm in male and > 80 cm in female) plus any two of the following four cardiometabolic risk factors:
•a. Blood pressure: Systolic BP >130 or diastolic BP> 85 mmHg
•b. Triglyceride: >1.7 mmol/l
•c. HDL-cholesterol: <1.03 mmol/l in males and < 1.29 mmol/ l in females
•d. Fasting plasma glucose>5.6 mmol/ l

•1.Women who are pregnant, lactating and/or in puerperium
•2.Patients with ischemic heart disease.
•3.Patients with diabetes mellitus (FBG> 7.0 mmol/l), hypertension (BP> 160/100 mmHg) or hypertriglyceridemia (Serum triglyceride > 5.65mmol/l)
•4.Patients of chronic inflammatory diseases, renal failure, hepatic or thyroid disorders
•5.Body Mass Index >40 kg/m2
•6.Patients using supplements containing antioxidants or anti-inflammatory drugs

发起方

AFIP / National University of Medical Sciences